Dr. Dino PratoEnvita Medical Centers · Founder and CEO at Envita Medical Centers

Cancer care is evolving and generative oncology is part of the shift #shorts

27 Dec 2025 · 1 min

Watch on YouTube

0:49

In this concise YouTube short, Dino Prato, NMD, introduces the emerging field of generative oncology as an evolution of precision oncology. He explains that by combining next‑generation DNA sequencing, RNA transcriptomics, immune profiling, and spatial biology, clinicians can gather over a thousand data points per tumor. Artificial intelligence, paired with physician expertise, integrates these multi‑omic hallmarks of cancer to design truly individualized treatment plans. These plans may include off‑label repurposed drugs, integrative natural agents, or bespoke immunotherapies—sometimes even therapies not yet commercially available. Prato emphasizes that this data‑driven, AI‑augmented approach represents the future of cancer care and underscores the need to retrain physicians so they can apply generative oncology in everyday practice.

Chapters

Today we're going to talk about generative oncology. A better way to understand precision oncology. How it's growing, how it works and how it's transforming care. We can scan the tumor's DNA next generation sequencing, RNA transcriptomics, immune profiling and spatial biology. Over a thousand plus data points and AI along with physician intelligence because you have to use both can pull from various hallmarks of cancer and generate the exact treatments to targeted for you. Whether it's a drug or something that isn't even currently available, an off label repurposed drug that's right for you, or an integrative natural agent or a plant, or an immunotherapy that has to be designed for you. This is the future of oncology. The data combining with the science and retraining physicians to be able to use this in their practice and help patients.